Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Debt Ratio (2016 - 2026)

Myriad Genetics has reported Debt Ratio over the past 9 years, most recently at 0.17 for Q4 2025.

  • Quarterly Debt Ratio rose 340.33% to 0.17 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.17 through Dec 2025, up 340.33% year-over-year, with the annual reading at 0.17 for FY2025, 340.33% up from the prior year.
  • Debt Ratio was 0.17 for Q4 2025 at Myriad Genetics, up from 0.16 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.17 in Q4 2025 and troughed at 0.03 in Q2 2023.
  • The 4-year median for Debt Ratio is 0.04 (2024), against an average of 0.07.
  • Year-over-year, Debt Ratio skyrocketed 3367.42% in 2021 and then increased 7.65% in 2024.
  • A 4-year view of Debt Ratio shows it stood at 0.08 in 2021, then crashed by 56.12% to 0.03 in 2023, then grew by 14.76% to 0.04 in 2024, then skyrocketed by 340.33% to 0.17 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Debt Ratio are 0.17 (Q4 2025), 0.16 (Q3 2025), and 0.09 (Q2 2025).